The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
abrdn Global Equity Impact Instl JETIX
- NAV / 1-Day Return 14.97 / +1.91 %
- Total Assets 43.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.900%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Global Large-Stock Growth
- Investment Style Large Growth
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 1.28%
- Turnover 31%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis JETIX
Will JETIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 41.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
ASML Holding NV | 5.00 | 2.2 Mil | Technology |
UnitedHealth Group Inc | 4.97 | 2.2 Mil | Healthcare |
RELX PLC | 4.94 | 2.2 Mil | Industrials |
Tetra Tech Inc | 4.69 | 2.1 Mil | Industrials |
Merck & Co Inc | 4.14 | 1.9 Mil | Healthcare |
Novo Nordisk A/S | 4.08 | 1.8 Mil | — |
NextEra Energy Inc | 3.89 | 1.7 Mil | Utilities |
AstraZeneca PLC | 3.60 | 1.6 Mil | Healthcare |
Prologis Inc | 3.27 | 1.5 Mil | Real Estate |
Insulet Corp | 3.06 | 1.4 Mil | Healthcare |